Skip to content

Search

The immortal legacy of Jette Ford

The Institute farewelled one of its most treasured employees this year, as The Kids Cancer Centre research officer Jette Ford closed the door on a quietly stellar 37-year career which has helped to change the face of cancer research in WA and around the world.

CliniKids puts the ‘evidence’ in evidence-based practice

Autism researchers at The Kids have led the most comprehensive review of the evidence for autism intervention ever compiled

Putting malaria on the map

A global network of researchers led by Kerry M Stokes Chair of Child Health, Professor Pete Gething, is working to help support informed decision-making for malaria control at international, regional and national scales.

Leveraging global lung health expertise to help preterm bubs

The world’s leading preterm scientists and doctors have joined forces to help give babies born very prematurely, the best possible life.

Precision health accelerator takes some of the guesswork out of research

Running any research project is a feat of logistical gymnastics – and often, you don’t know what can go wrong until it happens.

Finding the right recipe for youth mental health

In early 2021, The Kids Research Institute Australia researcher Dr Amy Finlay-Jones led a global team in trying to answer that question to help better prioritise mental health spending.

Research impact

Discover the impact of our achievements in the "real world".

SToP-ping skin sores in the Kimberley

More than 3,000 skin checks have been undertaken as part of a large clinical trial in WA’s Kimberley region aimed at halving the burden of skin sores in school-aged Aboriginal children.

Helping communities take charge of the early years

A program unfolding in four very diverse locations across Western Australia is working to give children aged 0–4 the best start in life.

Researchers make progress on 'superhero' phage therapy

Cystic fibrosis (CF) researchers are working hard to progress phage therapy as an alternative treatment to antibiotics in people with CF who develop life-threatening lung infections.